Search Results

You are looking at 141 - 150 of 1,574 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids

Neil J. Shah, Michael R. Cook, Tianmin Wu, Shaked Lev-Ari, Matthew J. Blackburn, Michael T. Serzan, Adil Alaoui, Jaeil Ahn, and Michael B. Atkins

reported. A Bonferroni-adjusted type I error 2.5% (5%/2) was used for statistical significance. R version 3.4 (R Foundation for Statistical Computing) was used for all statistical analyses. Results Patient Characteristics, irAEs, and Use of SS and

Full access

Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis

Daphna Y. Spiegel, Matthew J. Boyer, Julian C. Hong, Christina D. Williams, Michael J. Kelley, Joseph K. Salama, and Manisha Palta

resection and consideration of adjuvant chemotherapy (AC) based on patient and tumor characteristics. The role of AC in colon cancer is supported by the results of NSABP C01, 1 a pooled analysis, 2 and the MOSAIC trial 3 showing improvement in disease

Full access

Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework

Seanthel Delos Santos, Noah Witzke, Bishal Gyawali, Vanessa Sarah Arciero, Amanda Putri Rahmadian, Louis Everest, Matthew C. Cheung, and Kelvin K. Chan

assessed at the time of primary publication and at 3 years post-FDA approval using all publicly available data in eligible subsequent publications. Results Characteristics of Included Studies Of 113 indications that met the eligibility criteria, there were

Full access

Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma

Ritesh R. Kotecha, Ronan Flippot, Taylor Nortman, Annalisa Guida, Sujata Patil, Bernard Escudier, Robert J. Motzer, Laurence Albiges, and Martin H. Voss

clinical variables. R version 3.6.1 (R Foundation for Statistical Computing) was used for statistical analyses. Results Patient Characteristics From 2001 through 2019, 68 clinical trials conducted at Gustave Roussy and Memorial Sloan Kettering

Full access

Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery

Alyssa A. Schatz, Keysha Brooks-Coley, Elizabeth Harrington, Mary Stober Murray, and Robert W. Carlson

caregivers, respectively. The confidence interval at the 95% confidence level for a survey with a sample size of 600 is ±4.56%; for a sample size of 227 it is ±7.42%, and for a sample size of 238 it is ±7.24%. Table 1. Characteristics of Survey

Full access

First-Line Systemic Therapy Practice Patterns and Concordance With NCCN Guidelines for Patients Diagnosed With Metastatic NSCLC Treated at NCCN Institutions

Carrie Zornosa, Jonathan L. Vandergrift, Gregory P. Kalemkerian, David S. Ettinger, Michael S. Rabin, Mary Reid, Gregory A. Otterson, Marianna Koczywas, Thomas A. D'Amico, Joyce C. Niland, Rizvan Mamet, and Katherine M. Pisters

Member Institution. Data collection includes patient, disease, and treatment characteristics that are manually abstracted from medical records by trained data managers at each participating site. Data are abstracted for each patient in 6-month intervals

Full access

Determinants and Outcomes of Satisfaction With Healthcare Provider Communication Among Cancer Survivors

Ashish Rai, Xuesong Han, Zhiyuan Zheng, K. Robin Yabroff, and Ahmedin Jemal

characteristics (year 1 sociodemographic features, insurance status, usual source of care, comorbidity count, smoking status, active treatment status, tertile of office visits, any ED visits, and any inpatient care) and membership of the highest satisfaction

Full access

A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice

Pamala A. Pawloski, Gabriel A. Brooks, Matthew E. Nielsen, and Barbara A. Olson-Bullis

Background Clinical decision support (CDS) systems include any electronic system designed to directly aid clinical decision-making by using individual patient characteristics to generate patient-specific assessments or recommendations. 1 , 2 These

Full access

Barriers to Optimal End-of-Life Care for Adolescents and Young Adults With Cancer: Bereaved Caregiver Perspectives

Jennifer W. Mack, Erin R. Currie, Vincent Martello, Jordan Gittzus, Asisa Isack, Lauren Fisher, Lisa C. Lindley, Stephanie Gilbertson-White, Eric Roeland, and Marie Bakitas

( Table 3 ). Nearly half (46%) had Medicaid or other public insurance, and 54% lived in a low-income zip code (median income ≤200% FPL). Nearly half of caregivers were college graduates (46%). Table 2. AYA Caregiver Characteristics Table

Full access

Adjuvant Hormone Therapy–Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis

Erwei Zeng, Wei He, Karin E. Smedby, and Kamila Czene

Sweden, collecting detailed information on tumor characteristics and treatments. 15 , 16 The Swedish Prescribed Drug Register (SPDR) is a nationwide database that records all dispensed prescription drugs in pharmacies since July 2005, with <0.3% of data